Evidence map›Paper›PMID 40369557›Full record

ArticleMicrobial cell factories2025

Production and characterization of exopolysaccharides from Pseudomonas aeruginosa AG01 with some medical potential applications.

Amira Mohamed Ghanaim, Heba I Mohamed, Abeer E El-Ansary

Abstract read
In one paragraph

Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. LaponitePharmaceutics · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amira Mohamed GhanaimBiological and Geological Sciences Department, Faculty of Education, Ain Shams University, Cairo, 11341, Egypt.
Heba I MohamedBiological and Geological Sciences Department, Faculty of Education, Ain Shams University, Cairo, 11341, Egypt. hebaibrahim79@gmail.com.ORCID http://orcid.org/0000-0002-6892-3376
Abeer E El-AnsaryBiochemistry Department, Faculty of Agriculture, Cairo University, Gamma St, Giza, 12613, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is growing interest in the production and characterization of bacterial exopolysaccharides (EPS) because of their diverse range of applications. This study aimed to examine the production of EPS by Pseudomonas aeruginosa AG01, to characterize the produced EPS and its application as antioxidant, antimicrobial, antibiofilm, antitumor, and antiviral activity. The results indicated that the ideal conditions for achieving the highest production of EPS included an incubation period of 96 h, a pH level of 6, and a temperature of 32 °C in a nutrient broth medium. The most efficient sources of carbon and nitrogen for the formation of EPS were found to be galactose, glucose, yeast extract, and peptone. Several functional groups were confirmed to be present by Fourier transform infrared spectroscopy including amino groups, amides, carboxylic acids, hydroxyl groups, and phosphates. In the same respect, EPS has antioxidant activity. Moreover, EPS produced by Pseudomonas aeruginosa AG01 demonstrated antibacterial activity against various Gram-positive, Gram-negative bacteria, and yeast, besides antibiofilm activity about 98.93%, 98.86%, 98.63%, and 97.19% for Bacillus subtilis, Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli, respectively as well as anticancer activity against prostate cancer (PC3) and breast cancer (MCF7) cells with IC50 values of 156.41 and 156.41 µg/ml, respectively. Flow cytometry analysis revealed that MCF7 cells treated with EPS at a concentration of 500 µg/ml for 48 h showed a reduction in the percentage of cells in both the G0/G1 and S phases compared to the untreated control MCF7 cells. EPS resulted in apoptosis induction in MCF7 cells using the Annexin V-FITC PI staining method. The findings indicate that EPS demonstrates significant antiviral activity against both the herpes simplex virus (HSV-1) and the hepatitis A virus (HAV). In conclusion, EPS has great potential to be developed as a natural antioxidant or used in medicine and pharmaceuticals.

Indexed as

Polysaccharides, BacterialPseudomonas aeruginosaAnti-Bacterial AgentsAntineoplastic AgentsAntioxidantsAntiviral AgentsBiofilmsHumansMCF-7 CellsMicrobial Sensitivity TestsAnti-Bacterial AgentsAntineoplastic AgentsAntioxidantsAntiviral AgentsPolysaccharides, BacterialAntibiofilmAntimicrobialAntioxidantAntitumorAntiviralFT-IRHPLC

Identifiers

PMID40369557
PMCPMC12077034

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.